Skip to main content
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mSphere
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Observation | Clinical Science and Epidemiology

IMP-68, a Novel IMP-Type Metallo-β-Lactamase in Imipenem-Susceptible Klebsiella pneumoniae

Hiroaki Kubota, Yasunori Suzuki, Rumi Okuno, Yumi Uchitani, Tsukasa Ariyoshi, Nobuyuki Takemura, Fuminori Mihara, Kazuhisa Mezaki, Norio Ohmagari, Mari Matsui, Satowa Suzuki, Tsuyoshi Sekizuka, Makoto Kuroda, Keiko Yokoyama, Kenji Sadamasu
Mariana Castanheira, Editor
Hiroaki Kubota
aDepartment of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hiroaki Kubota
Yasunori Suzuki
aDepartment of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yasunori Suzuki
Rumi Okuno
aDepartment of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yumi Uchitani
aDepartment of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tsukasa Ariyoshi
aDepartment of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tsukasa Ariyoshi
Nobuyuki Takemura
bDepartment of Hepato-Biliary Pancreatic Surgery, National Center for Global Health and Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nobuyuki Takemura
Fuminori Mihara
bDepartment of Hepato-Biliary Pancreatic Surgery, National Center for Global Health and Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuhisa Mezaki
cMicrobiology Laboratory, National Center for Global Health and Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norio Ohmagari
dDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Norio Ohmagari
Mari Matsui
eAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mari Matsui
Satowa Suzuki
eAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Satowa Suzuki
Tsuyoshi Sekizuka
fPathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tsuyoshi Sekizuka
Makoto Kuroda
fPathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Makoto Kuroda
Keiko Yokoyama
aDepartment of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenji Sadamasu
aDepartment of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kenji Sadamasu
Mariana Castanheira
JMI Laboratories
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mSphere.00736-19
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

We recently detected a novel variant of an IMP-type metallo-β-lactamase gene (blaIMP-68) from meropenem-resistant but imipenem-susceptible Klebsiella pneumoniae TA6363 isolated in Tokyo, Japan. blaIMP-68 encodes a Ser262Gly point mutant of IMP-11, and transformation experiments showed that blaIMP-68 increased the MIC of carbapenems in recipient strains, whereas the MIC of imipenem was not greatly increased relative to that of other carbapenems, including meropenem. Kinetics experiments showed that IMP-68 imipenem-hydrolyzing activity was lower than that for other carbapenems, suggesting that the antimicrobial susceptibility profile of TA6363 originated from IMP-68 substrate specificity. Whole-genome sequencing showed that blaIMP-68 is harbored by the class 1 integron located on the IncL/M plasmid pTMTA63632 (88,953 bp), which was transferable via conjugation. The presence of plasmid-borne blaIMP-68 is notable, because it conferred antimicrobial resistance to carbapenems, except for imipenem, on Enterobacteriaceae and will likely affect treatment plans using antibacterial agents in clinical settings.

IMPORTANCE IMP-type metallo-β-lactamases comprise one group of the “Big 5” carbapenemases. Here, a novel blaIMP-68 gene encoding IMP-68 (harboring a Ser262Gly point mutant of IMP-11) was discovered from meropenem-resistant but imipenem-susceptible Klebsiella pneumoniae TA6363. The Ser262Gly substitution was previously identified as important for substrate specificity according to a study of other IMP variants, including IMP-6. We confirmed that IMP-68 exhibited weaker imipenem-hydrolyzing activity than that for other carbapenems, demonstrating that the antimicrobial susceptibility profile of TA6363 originated from IMP-68 substrate specificity, with this likely to affect treatment strategies using antibacterial agents in clinical settings. Notably, the carbapenem resistance conferred by IMP-68 was undetectable based on the MIC of imipenem as a carbapenem representative, which demonstrates a comparable antimicrobial susceptibility profile to IMP-6-producing Enterobacteriaceae that previously spread in Japan due to lack of awareness of its existence.

OBSERVATION

IMP-type metallo-β-lactamases are among the most common families of acquired carbapenemases detected from Enterobacteriaceae and have been reported mainly in East Asia, including Japan (1). Although IMP-type metallo-β-lactamases generally hydrolyze carbapenems, this activity on imipenem by several IMP variants, including IMP-6, is weak (2–4). IMP-1 Ser262 is replaced with glycine in these variants, and Enterobacteriaceae encoding IMP-6 frequently show susceptibility to imipenem. This feature caused the spread of blaIMP-6-harboring plasmids in Japan as determined after screening the antibiotic susceptibility of infectious bacteria to imipenem as a representative carbapenem (5–7). Here, we report a novel variant, IMP-68, which is a point mutant of IMP-11 corresponding to the Ser262Gly substitution.

Klebsiella pneumoniae TA6363 was isolated from ascites obtained from a hospitalized male patient suffering from peritonitis at the National Center of Global Health and Medicine in 2016. The patient was suspected to be domestically infected by this pathogen, because he had not been abroad from Japan within at least 90 days. This study was approved by the ethics committee of the Tokyo Metropolitan Institute of Public Health. TA6363 was initially determined to be resistant to meropenem by MicroScan walkaway 96 SI (Beckman Coulter, Brea, CA, USA) using the MicroScan Neg Combo EN 1T test card (Beckman Coulter), which employs meropenem as a carbapenem representative. However, this strain was subsequently found to be susceptible to imipenem using the dry strip method using Etest (bioMérieux, La Balme-Les-Grottes, France) (Table 1). TA6363 was positive for a modified carbapenem-inactivation method (8) and found to produce metallo-β-lactamase using the double-disk synergy test involving meropenem and sodium mercaptoacetate (Eiken Chemical, Tokyo, Japan) disks. Pulsed-field gel electrophoresis using an S1-nuclease-digested DNA plug (S1-PFGE) showed that TA6363 carried three plasmids (Fig. 1), with the second larger one (pTMTA63632; ∼90 kbp) harboring the novel blaIMP gene according to sequencing plasmids extracted from the S1-PFGE gel (MiSeq; Illumina, San Diego, CA, USA) (9, 10). We found that this blaIMP gene encoded a Ser262Gly point mutant of IMP-11 metallo-β-lactamase, and we named this novel variant “blaIMP-68” (see Fig. S1 in the supplemental material).

View this table:
  • View inline
  • View popup
  • Download powerpoint
TABLE 1

MICs of selected antimicrobial agents for the K. pneumoniae TA6363 strain and for the transformants and transconjugants carrying blaIMP-68 or blaIMP-11

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

The blaIMP-68-carrying plasmid pTMTA63632. S1-PFGE pattern of TA6363 showing that three plasmids were carried by TA6363 (left). The circular map of pTMTA63632 (right), which harbored blaIMP-68, was generated by GView server (https://server.gview.ca/).

FIG S1

Amino acid sequences of IMP variants. The differences in amino acid residues between IMP-1 (or IMP-6) and IMP-68 (or IMP-11) are highlighted in light blue. The residues corresponding to the Ser262Gly substitution are highlighted in magenta. Download FIG S1, TIF file, 1.5 MB.
Copyright © 2019 Kubota et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

We tested the influence of IMP-68 on antibiotic resistance to β-lactams by transformation experiments. We cloned the open reading frame of blaIMP-68 into a chloramphenicol-resistant pHSG398 vector (Takara Bio, Shiga, Japan) at the EcoRI-KpnI site and used it to transform Escherichia coli DH5α cells (Takara Bio). Additionally, we tested blaIMP-11 for comparison, and conjugation transfer was tested using E. coli J53, as previously described (9). The MICs of β-lactams were determined by the dry strip method using Etest. To determine whether IMP-68 production was detectable by several phenotypic tests other than the modified carbapenem-inactivation method, TA6363 and the E. coli J53 transconjugant were applied to the modified Hodge (11), Carba NP (12), and Blue-Carba (13) tests.

To purify IMP-11 and IMP-68, the nucleotide sequence for the restriction site of the PreScission protease (GE Healthcare, Chicago, IL, USA) was added to the N terminus of blaIMP-11 and blaIMP-68 after the signal peptide region (first 19 amino acids) by PCR, followed by cloning into the pETBK vector (BioDynamics, Tokyo, Japan) for expression in E. coli Rosetta II cells (Merck-Millipore, Darmstadt, Germany). His-tagged proteins were purified using a nickel-nitrilotriacetic acid (Ni-NTA) resin (Qiagen, Hilden, Germany) and digested by PreScission protease to remove the His tag.

Kinetics experiments were performed by spectrophotometry (14–16), with initial hydrolysis rates for each β-lactam measured using a Biomate 3 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) at 298 nm for imipenem and meropenem, 260 nm for ceftazidime and cefotaxime, and 235 nm for ampicillin at 24 ± 1°C in 50 mM sodium phosphate buffer (pH 7.0) supplemented with 50 μM ZnCl2. Km and kcat values were determined by the Michaelis-Menten equation. Experiments were performed in triplicate.

Table 1 shows the MICs for TA6363 and E. coli transformants. Although TA6363 was resistant to meropenem, doripenem, and ertapenem, the MIC of imipenem for TA6363 was classified as susceptible (S) according to Clinical and Laboratory Standards Institute criteria (12). E. coli transformation by blaIMP-68 alone significantly increased the MICs of β-lactams, and the substrate specificity of IMP-68 and IMP-11 differed. The lower MIC of imipenem for IMP-68 than that for IMP-11 was similar to the relationship between IMP-6 and IMP-1, where the MIC of imipenem for IMP-6 is lower than that for IMP-1 (2). Furthermore, the blaIMP-68-carrying native plasmid pTMTA63632 was transferred by conjugation from TA6363 to E. coli J53, resulting in enhanced antibiotic resistance via pTMTA63632. TA6363 and the transconjugant were positive for all the above-mentioned tested phenotypic methods. Despite the use of imipenem, the Carba NP and Blue-Carba tests were sensitive enough to detect IMP-68 production.

Several differences in substrate specificity between IMP-11 and IMP-68 identified during antibiotic susceptibility testing were consistent with the results of kinetics experiments (Table 2). The kcat/Km values of IMP-68 against imipenem were lower than those of IMP-11, whereas IMP-68 exhibited higher meropenem-hydrolyzing activity. Additionally, the kcat/Km values of IMP-68 against ceftazidime were lower than those of IMP-11. These differences in substrate specificity between IMP-68 and IMP-11 correlated with those between IMP-6 and IMP-1 (2).

View this table:
  • View inline
  • View popup
  • Download powerpoint
TABLE 2

Kinetic parameters of IMP-11 and IMP-68

Additionally, genomic DNA extracted from TA6363 was sequenced on MiSeq and MinION platforms (Oxford Nanopore, Oxford, United Kingdom), and the obtained reads were assembled by Unicycler (v.0.4.7) (17). Genes were predicted and annotated using Prokka (v.1.11) (18), NCBI BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi), and ResFinder (v.3.1) (19). The Inc types of the plasmids were determined by PlasmidFinder (v.2.0) (20), with the threshold of nucleotide coverage and identity used for Inc-type identification established at 96% and 98%, respectively (21).

We obtained four circular sequences (Table S1) corresponding to a chromosome and three plasmids (Fig. 1 and Fig. S2). TA6363 was classified as ST268, and pTMTA63632 was determined to be an IncL/M plasmid. Chromosomal mutations corresponding to antimicrobial resistance to carbapenems (ompK36, ompK37, and acrR) and fluoroquinolones (gyrA and parC) were not found (Table S1). Class 1-integron-harboring blaIMP-68 in pTMTA63632 (Fig. 1), which was assigned to In1702 in the INTEGRALL database (22), was similar to previously reported IMP genes harboring class 1 integrons, as the gene cassettes were located between intI1 and qacEΔ1-sul1 (10, 23, 24). Specifically, In1702 was compared with the class 1 integrons harbored by pNUH14_ECL028_1 and pIMP-A2015-49 plasmids previously found in Japan (24), which carried IMP-1 and IMP-11, respectively (Fig. S3). The inclusion of conjugation transfer genes by pTMTA63632 was consistent with the conjugation experiment performed using E. coli J53 (Table 1). The higher MICs of ampicillin and piperacillin for the transconjugant than for blaIMP-68 alone (Table 1) likely originated from the effect of blaTEM-1 in pTMTA63632. TA6363 was resistant to both amikacin and gentamicin, whereas the transconjugant was resistant only to amikacin. This difference was attributable to the carriage of aminoglycoside resistance genes by pTMTA63632 [aac(6′)-Ia] and pTMTA63633 [aac(3)-IId, aph(3′)-Ib, and aph(6)-Id] (Table S1) (25); namely, pTMTA63632 conferred antimicrobial resistance to amikacin, whereas pTMTA63633 was additionally necessary for the gentamicin resistance.

FIG S2

Circular maps of plasmids pTMTA63631 and pTMTA63633. These maps were generated by GView server (https://server.gview.ca/). Conjugative transfer genes were not detected in these plasmids. Download FIG S2, TIF file, 1.7 MB.
Copyright © 2019 Kubota et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

FIG S3

Comparison of blaIMP-harboring integrons isolated in Japan. The Artemis comparison tool was used to compare In1702 in pTMTA63632 with previously reported blaIMP-1- and blaIMP-11-harboring integrons. These integrons were found in plasmids pNUH_ECL028_1 (for blaIMP-1) and pTMP-A2015-49 (for blaIMP-11) carried by bacteria isolated in Japan in 2014 and 2015, respectively. Because the original data for pNUH_ECL028_1 were submitted to a database without gene annotation, we predicted and annotated its genes by the same method with pTMTA63632 in this study (see text). Similar regions (BLAST score of >300 and identity of >85%) are shown by magenta lines. Downstream sequence of pTMP-A2015-49 was not registered in the database and thus could not be compared with pTMTA63632. The open reading frames colored in light blue and gray indicate antimicrobial resistance genes and transposases, respectively. Download FIG S3, TIF file, 1.0 MB.
Copyright © 2019 Kubota et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S1

Profiles of the TA6363 chromosome and plasmids. Download Table S1, DOCX file, 0.02 MB.
Copyright © 2019 Kubota et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

In conclusion, IMP-68 should be noted as a novel carbapenemase that does not sufficiently confer resistance to imipenem on Enterobacteriaceae due to the Ser262Gly substitution from IMP-11. IMP-68 production would have been missed if the MIC of imipenem had been used to investigate the carbapenemase-producing Enterobacteriaceae. The diversity of substrate specificity among IMP-type enzymes might affect treatment plans using antibacterial agents in clinical settings.

Data availability.We deposited the blaIMP-68 sequence in GenBank (MF669572) and the whole-genome sequence of TA6363 containing chromosome (AP019665), pTMTA63631 (AP019666), pTMTA63632 (AP019667), and pTMTA63633 (AP019668) in the DNA Data Bank of Japan (DDBJ).

ACKNOWLEDGMENTS

This work was supported by the Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development, AMED (grants 17fk0108121j and 18fk0108048j) and by a grant for Research on Emerging and Re-emerging Infectious Diseases and Immunization from the Japanese Ministry of Health, Labour and Welfare (grant H28-Shinko Gyosei-Ippan-006).

FOOTNOTES

    • Received October 11, 2019.
    • Accepted October 16, 2019.
  • Copyright © 2019 Kubota et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

REFERENCES

  1. 1.↵
    1. Nordmann P,
    2. Poirel L
    . 2014. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect 20:821–830. doi:10.1111/1469-0691.12719.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Yano H,
    2. Kuga A,
    3. Okamoto R,
    4. Kitasato H,
    5. Kobayashi T,
    6. Inoue M
    . 2001. Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrob Agents Chemother 45:1343–1348. doi:10.1128/AAC.45.5.1343-1348.2001.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Iyobe S,
    2. Kusadokoro H,
    3. Ozaki J,
    4. Matsumura N,
    5. Minami S,
    6. Haruta S,
    7. Sawai T,
    8. O’Hara K
    . 2000. Amino acid substitutions in a variant of IMP-1 metallo-beta-lactamase. Antimicrob Agents Chemother 44:2023–2027. doi:10.1128/aac.44.8.2023-2027.2000.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Tada T,
    2. Nhung PH,
    3. Miyoshi-Akiyama T,
    4. Shimada K,
    5. Phuong DM,
    6. Anh NQ,
    7. Ohmagari N,
    8. Kirikae T
    . 2015. IMP-51, a novel IMP-type metallo-β-lactamase with increased doripenem- and meropenem-hydrolyzing activities, in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 59:7090–7093. doi:10.1128/AAC.01611-15.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Yano H,
    2. Ogawa M,
    3. Endo S,
    4. Kakuta R,
    5. Kanamori H,
    6. Inomata S,
    7. Ishibashi N,
    8. Aoyagi T,
    9. Hatta M,
    10. Gu Y,
    11. Yamada M,
    12. Tokuda K,
    13. Kunishima H,
    14. Kitagawa M,
    15. Hirakata Y,
    16. Kaku M
    . 2012. High frequency of IMP-6 among clinical isolates of metallo-β-lactamase-producing Escherichia coli in Japan. Antimicrob Agents Chemother 56:4554–4555. doi:10.1128/AAC.00617-12.
    OpenUrlFREE Full Text
  6. 6.↵
    1. Shigemoto N,
    2. Kuwahara R,
    3. Kayama S,
    4. Shimizu W,
    5. Onodera M,
    6. Yokozaki M,
    7. Hisatsune J,
    8. Kato F,
    9. Ohge H,
    10. Sugai M
    . 2012. Emergence in Japan of an imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae carrying blaIMP-6. Diagn Microbiol Infect Dis 72:109–112. doi:10.1016/j.diagmicrobio.2011.09.019.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Kanazawa S,
    2. Sato T,
    3. Kohira N,
    4. Ito-Horiyama T,
    5. Tsuji M,
    6. Yamano Y
    . 2017. Susceptibility of imipenem-susceptible but meropenem-resistant blaIMP-6-carrying Enterobacteriaceae to various antibacterials, including the siderophore cephalosporin cefiderocol. Antimicrob Agents Chemother 61:e00576-17. doi:10.1128/AAC.00576-17.
    OpenUrlFREE Full Text
  8. 8.↵
    1. Pierce VM,
    2. Simner PJ,
    3. Lonsway DR,
    4. Roe-Carpenter DE,
    5. Johnson JK,
    6. Brasso WB,
    7. Bobenchik AM,
    8. Lockett ZC,
    9. Charnot-Katsikas A,
    10. Ferraro MJ,
    11. Thomson RB, Jr,
    12. Jenkins SG,
    13. Limbago BM,
    14. Das S
    . 2017. Modified carbapenem inactivation method (mCIM) for phenotypic detection of carbapenemase production among Enterobacteriaceae. J Clin Microbiol 55:2321–2333. doi:10.1128/JCM.00193-17.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Kubota H,
    2. Uwamino Y,
    3. Matsui M,
    4. Sekizuka T,
    5. Suzuki Y,
    6. Okuno R,
    7. Uchitani Y,
    8. Ariyoshi T,
    9. Aoki W,
    10. Suzuki S,
    11. Kuroda M,
    12. Shinkai T,
    13. Yokoyama K,
    14. Sadamasu K,
    15. Funakoshi T,
    16. Murata M,
    17. Hasegawa N,
    18. Iwata S
    . 2018. FRI-4 carbapenemase-producing Enterobacter cloacae complex isolated in Tokyo, Japan. J Antimicrob Chemother 73:2969–2972. doi:10.1093/jac/dky291.
    OpenUrlCrossRef
  10. 10.↵
    1. Sekizuka T,
    2. Matsui M,
    3. Takahashi T,
    4. Hayashi M,
    5. Suzuki S,
    6. Tokaji A,
    7. Kuroda M
    . 2018. Complete genome sequence of blaIMP-6-positive Metakosakonia sp. MRY16-398 isolate from the ascites of a diverticulitis patient. Front Microbiol 9:2853. doi:10.3389/fmicb.2018.02853.
    OpenUrlCrossRef
  11. 11.↵
    Clinical and Laboratory Standards Institute. 2017. Performance standards for antimicrobial susceptibility testing; 27th informational supplement. CLSI Document M100. CLSI, Wayne, PA.
  12. 12.↵
    Clinical and Laboratory Standards Institute. 2019. Performance standards for antimicrobial susceptibility testing; 29th informational supplement. CLSI Document M100. CLSI, Wayne, PA.
  13. 13.↵
    1. Pires J,
    2. Novais A,
    3. Peixe L
    . 2013. Blue-carba, an easy biochemical test for detection of diverse carbapenemase producers directly from bacterial cultures. J Clin Microbiol 51:4281–4283. doi:10.1128/JCM.01634-13.
    OpenUrlFREE Full Text
  14. 14.↵
    1. Poirel L,
    2. Le Thomas I,
    3. Naas T,
    4. Karim A,
    5. Nordmann P
    . 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob Agents Chemother 44:622–632. doi:10.1128/aac.44.3.622-632.2000.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Boschi L,
    2. Mercuri PS,
    3. Riccio ML,
    4. Amicosante G,
    5. Galleni M,
    6. Frère JM,
    7. Rossolini GM
    . 2000. The Legionella (Fluoribacter) gormanii metallo-beta-lactamase: a new member of the highly divergent lineage of molecular-subclass B3 beta-lactamases. Antimicrob Agents Chemother 44:1538–1543. doi:10.1128/aac.44.6.1538-1543.2000.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Queenan AM,
    2. Shang W,
    3. Flamm R,
    4. Bush K
    . 2010. Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem. Antimicrob Agents Chemother 54:565–569. doi:10.1128/AAC.01004-09.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Wick RR,
    2. Judd LM,
    3. Gorrie CL,
    4. Holt KE
    . 2017. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 13:e1005595. doi:10.1371/journal.pcbi.1005595.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Seemann T
    . 2014. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30:2068–2069. doi:10.1093/bioinformatics/btu153.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Zankari E,
    2. Hasman H,
    3. Cosentino S,
    4. Vestergaard M,
    5. Rasmussen S,
    6. Lund O,
    7. Aarestrup FM,
    8. Larsen MV
    . 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640–2644. doi:10.1093/jac/dks261.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Carattoli A,
    2. Zankari E,
    3. García-Fernández A,
    4. Voldby Larsen M,
    5. Lund O,
    6. Villa L,
    7. Møller Aarestrup F,
    8. Hasman H
    . 2014. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother 58:3895–3903. doi:10.1128/AAC.02412-14.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Carattoli A,
    2. Bertini A,
    3. Villa L,
    4. Falbo V,
    5. Hopkins KL,
    6. Threlfall EJ
    . 2005. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63:219–228. doi:10.1016/j.mimet.2005.03.018.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Moura A,
    2. Soares M,
    3. Pereira C,
    4. Leitão N,
    5. Henriques I,
    6. Correia A
    . 2009. INTEGRALL: a database and search engine for integrons, integrases and gene cassettes. Bioinformatics 25:1096–1098. doi:10.1093/bioinformatics/btp105.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Zhao WH,
    2. Chen G,
    3. Ito R,
    4. Kimura S,
    5. Hu ZQ
    . 2012. Identification of a plasmid-borne blaIMP-11 gene in clinical isolates of Escherichia coli and Klebsiella pneumoniae. J Med Microbiol 61:246–251. doi:10.1099/jmm.0.035626-0.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Tetsuka N,
    2. Hirabayashi A,
    3. Matsumoto A,
    4. Oka K,
    5. Hara Y,
    6. Morioka H,
    7. Iguchi M,
    8. Tomita Y,
    9. Suzuki M,
    10. Shibayama K,
    11. Yagi T
    . 2019. Molecular epidemiological analysis and risk factors for acquisition of carbapenemase-producing Enterobacter cloacae complex in a Japanese university hospital. Antimicrob Resist Infect Control 8:126. doi:10.1186/s13756-019-0578-3.
    OpenUrlCrossRef
  25. 25.↵
    1. Shaw KJ,
    2. Rather PN,
    3. Hare RS,
    4. Miller GH
    . 1993. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev 57:138–163.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
IMP-68, a Novel IMP-Type Metallo-β-Lactamase in Imipenem-Susceptible Klebsiella pneumoniae
Hiroaki Kubota, Yasunori Suzuki, Rumi Okuno, Yumi Uchitani, Tsukasa Ariyoshi, Nobuyuki Takemura, Fuminori Mihara, Kazuhisa Mezaki, Norio Ohmagari, Mari Matsui, Satowa Suzuki, Tsuyoshi Sekizuka, Makoto Kuroda, Keiko Yokoyama, Kenji Sadamasu
mSphere Oct 2019, 4 (5) e00736-19; DOI: 10.1128/mSphere.00736-19

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print
Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mSphere article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
IMP-68, a Novel IMP-Type Metallo-β-Lactamase in Imipenem-Susceptible Klebsiella pneumoniae
(Your Name) has forwarded a page to you from mSphere
(Your Name) thought you would be interested in this article in mSphere.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
IMP-68, a Novel IMP-Type Metallo-β-Lactamase in Imipenem-Susceptible Klebsiella pneumoniae
Hiroaki Kubota, Yasunori Suzuki, Rumi Okuno, Yumi Uchitani, Tsukasa Ariyoshi, Nobuyuki Takemura, Fuminori Mihara, Kazuhisa Mezaki, Norio Ohmagari, Mari Matsui, Satowa Suzuki, Tsuyoshi Sekizuka, Makoto Kuroda, Keiko Yokoyama, Kenji Sadamasu
mSphere Oct 2019, 4 (5) e00736-19; DOI: 10.1128/mSphere.00736-19
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • OBSERVATION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Enterobacteriaceae
Klebsiella
antibiotic resistance
carbapenems
enzyme kinetics
genome analysis
plasmid-mediated resistance

Related Articles

Cited By...

About

  • About mSphere
  • Board of Editors
  • Policies
  • For Reviewers
  • For the Media
  • Embargo Policy
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Types of Articles
  • Getting Started
  • Ethics
  • Contact Us

Follow #mSphereJ

@ASMicrobiology

       

 

Website feedback

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2379-5042